The offices are part of the authority's FDA With Borders Initiative announced few months ago.
The FDA "believes we can better help assure the safety and manufacturing quality of these products by having FDA personnel full time in India to work with our counterpart agencies there," the newsletter quoted Christopher Kelly, a spokesman for the FDA's Office of International Programs.
Kelly said the offices will help the agency make better, more risk-based decisions on where to use its inspection resources
